Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Pharmaceutics
|
July 30, 2025
Could Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists Play a Role in Gout Treatment?
Dan Kaufmann, Naomi Schlesinger
Current Rheumatology Reports
|
March 21, 2026
Is Gout an Autoinflammatory Disease?
Naomi Schlesinger, Dan Kaufmann
Current Opinion in Rheumatology
|
September 8, 2025
Updates in uricase therapy for gout
Naomi Schlesinger, Dan Kaufmann
Current Rheumatology Reports
|
June 9, 2026
Correction to: Is Gout and Autoinflammatory Disease?
Naomi Schlesinger, Dan Kaufmann
Frontiers in Cellular Neuroscience
|
October 5, 2018
The Effects of Chronic Stress on Migraine Relevant Phenotypes in Male Mice
Dan Kaufmann, K C Brennan
Joint Bone Spine
|
December 2, 2024
Optimizing gout treatment: A comprehensive review of current and emerging uricosurics
Dan Kaufmann, Nathorn Chaiyakunapruk, Naomi Schlesinger
Frontiers in Behavioral Neuroscience
|
May 26, 2023
Editorial: The affective aspects of chronic pain and potential treatments
Dan Kaufmann, Brandon C Yarns, Parisa Gazerani
Journal of Medicinal Chemistry
|
November 3, 2009
Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues
Dan Kaufmann, Meir Bialer, Jakob Avi Shimshoni, et al.
Neuropharmacology
|
January 19, 2008
Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide
Dan Kaufmann, Boris Yagen, Anne Minert, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
August 2, 2008
Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice
Akinobu Okada, Yuko Onishi, Boris Yagen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Pharmaceutics
|
July 30, 2025
Could Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists Play a Role in Gout Treatment?
Dan Kaufmann, Naomi Schlesinger
Current Rheumatology Reports
|
March 21, 2026
Is Gout an Autoinflammatory Disease?
Naomi Schlesinger, Dan Kaufmann
Current Opinion in Rheumatology
|
September 8, 2025
Updates in uricase therapy for gout
Naomi Schlesinger, Dan Kaufmann
Current Rheumatology Reports
|
June 9, 2026
Correction to: Is Gout and Autoinflammatory Disease?
Naomi Schlesinger, Dan Kaufmann
Frontiers in Cellular Neuroscience
|
October 5, 2018
The Effects of Chronic Stress on Migraine Relevant Phenotypes in Male Mice
Dan Kaufmann, K C Brennan
Joint Bone Spine
|
December 2, 2024
Optimizing gout treatment: A comprehensive review of current and emerging uricosurics
Dan Kaufmann, Nathorn Chaiyakunapruk, Naomi Schlesinger
Frontiers in Behavioral Neuroscience
|
May 26, 2023
Editorial: The affective aspects of chronic pain and potential treatments
Dan Kaufmann, Brandon C Yarns, Parisa Gazerani
Journal of Medicinal Chemistry
|
November 3, 2009
Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues
Dan Kaufmann, Meir Bialer, Jakob Avi Shimshoni, et al.
Neuropharmacology
|
January 19, 2008
Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide
Dan Kaufmann, Boris Yagen, Anne Minert, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
August 2, 2008
Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice
Akinobu Okada, Yuko Onishi, Boris Yagen, et al.
Page
of 2